Mark E. Saad

Companies

• Axsome TherapeuticsBoard member Nov 19, 2015 to now¹
• Flyte Aviation, Inc.Board member Sep 26, 2018 to Jan 7, 2021²
• Plus TherapeuticsChief financial officer Jan 26, 2006 to Apr 15, 2014³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAxsome Therapeutics AXSM11,731 shares⁴$1.8M at $157.14Jun 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 8, 2026Exercised options 1,429 shares of Axsome Therapeutics⁴
• Dec 31, 2025Sold 31,346 shares at $165.18 of Axsome Therapeutics⁵
• Dec 31, 2025Exercised options 31,346 shares at $4.95 of Axsome Therapeutics⁵
• Dec 31, 2025Sold 6,231 shares at $165.18 of Axsome Therapeutics⁵
• Dec 31, 2025Exercised options 6,231 shares at $8.02 of Axsome Therapeutics⁵
• Sep 5, 2025Sold 9,127 shares at $125.07 of Axsome Therapeutics⁶
• Sep 5, 2025Exercised options 9,127 shares at $9.00 of Axsome Therapeutics⁶
• Sep 11, 2024Sold 11,016 shares at $91.31 of Axsome Therapeutics⁷
• Sep 11, 2024Exercised options 11,016 shares at $3.67 of Axsome Therapeutics⁷
• Nov 17, 2021Bought 100 shares at $34.40 of Axsome Therapeutics⁸
• Nov 17, 2021Bought 100 shares at $34.45 of Axsome Therapeutics⁸
• Nov 17, 2021Bought 100 shares at $34.40 of Axsome Therapeutics⁸
• Nov 17, 2021Bought 3,000 shares at $34.53 of Axsome Therapeutics⁸